Yamauchi K, Green D R, Eardley D D, Murphy D B, Gershon R K
J Exp Med. 1981 Jun 1;153(6):1547-61. doi: 10.1084/jem.153.6.1547.
The in vitro antibody response of spleen cells from B10 strain mice is not suppressed by factor preparations made by primed Ly-2 T cells, although these preparations can suppress the in vitro antibody response of spleen cells from other mouse strains (1-3)2. The factor preparations from Ly-2 cells contain at least two separable activities: one that acts as a suppressor moiety (Ly-2 T cell suppressor factor [Ly-2 TsF]) and a second factor that acts as an inducer of contrasuppression (Ly-2 TcsiF); the latter initiates a series of cellular interactions that leads to the inhibition of suppression that we refer to as contrasuppression. Removal of components (either cellular or humoral) of the contrasuppressor circuit makes spleen cells from B10 strain mice as easily suppressible as are those of other mouse strains. Thus, removal of the contrasuppressor inducer cell and/or its biologically active product with the use of an anit-J serum, or removal of the functional acceptor of the inducer cell with the same or other (Ly-2; Qa-1) antisera breaks the B10 suppressor barrier. Contrasuppressive activity. but not helper activity can be eluted from anit-I-J immunoabsorbents. The addition of B10 T cells to either B6 or B10 spleen cell culture deprived of acceptor cells for the TcsiF reconstitutes contrasuppression more efficiently than does the addition of C57BL/6 T cells. Ly-2 TcsiF is more cross-reactive than is Ly-2 TsF so that absorption of factor preparations from sheep erythrocyte-primed Ly-2 cells with horse erythrocytes also breaks the B10 suppressor barrier. The hyperresponsiveness of splenic T cells from B10 strains to Ly-2 TcsiF may be an in vitro exaggeration of a normal in vivo process. Thus it is possible that one can take advantage of this unusual situation to help dissect out the cellular and subcellular components of T cell circuits that moldulate sensitivity to immunoregulatory signals.
B10品系小鼠脾细胞的体外抗体应答不受经致敏的Ly-2 T细胞制备的因子制剂的抑制,尽管这些制剂可抑制其他小鼠品系脾细胞的体外抗体应答(1-3)2。来自Ly-2细胞的因子制剂至少含有两种可分离的活性:一种作为抑制部分起作用(Ly-2 T细胞抑制因子[Ly-2 TsF]),另一种作为抗抑制诱导因子起作用(Ly-2 TcsiF);后者启动一系列细胞间相互作用,导致抑制作用受到抑制,我们将其称为抗抑制。去除抗抑制回路的成分(细胞成分或体液成分)会使B10品系小鼠的脾细胞与其他小鼠品系的脾细胞一样易于被抑制。因此,使用抗I-J血清去除抗抑制诱导细胞和/或其生物活性产物,或使用相同或其他(Ly-2;Qa-1)抗血清去除诱导细胞的功能性受体,可打破B10抑制屏障。抗抑制活性而非辅助活性可从抗I-J免疫吸附剂上洗脱下来。将B10 T细胞添加到缺乏TcsiF受体细胞的B6或B10脾细胞培养物中,比添加C57BL/6 T细胞能更有效地重建抗抑制作用。Ly-2 TcsiF比Ly-2 TsF具有更强的交叉反应性,因此用马红细胞吸收来自经绵羊红细胞致敏的Ly-2细胞的因子制剂也会打破B10抑制屏障。B10品系脾T细胞对Ly-2 TcsiF的高反应性可能是正常体内过程在体外的一种夸大表现。因此,有可能利用这种特殊情况来帮助剖析调节对免疫调节信号敏感性的T细胞回路的细胞和亚细胞成分。